ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

New Treatment in Western PA that Heals Neuropathy and Controls Neuropathy Pain

Mercy Family Health introduces StemWave Acoustic Wave Therapy, a non-invasive treatment for neuropathy. The protocol uses acoustic waves to support nerve tissue healing and manage pain, offering a new option for individuals with chronic nerve damage and discomfort.

-- Mercy Family Health announces the availability of StemWave Acoustic Wave Therapy, a new protocol for individuals who need relief from nerve damage. This approach is designed to support the healing of nerve tissue and provide effective pain control for those with neuropathy. The therapy offers a non-invasive option for people managing the chronic discomfort and functional limitations associated with this widespread condition.

More information is available at https://www.americastruehealth.com/blog/stemwave-shockwave-therapy-and-hope-for-peripheral-neuropathy.

The need for effective solutions is significant, as peripheral neuropathy affects a large portion of the population. The condition is a substantial public health challenge. For instance, its prevalence is high among individuals with long-term diabetes, where it can severely impact daily life. The condition often leads to chronic pain, foot ulcers, and other complications that diminish quality of life and mobility.

The StemWave treatment employs acoustic wave technology to address the underlying physiological causes of nerve damage. These unfocused energy waves penetrate tissue to improve blood circulation and stimulate the body's natural repair mechanisms in affected areas. This process helps reduce inflammation and supports the healing and regeneration of damaged nerve tissue. The therapy's ability to cover a larger area makes it suitable for the diffuse nature of nerve damage.

Clinical application of the protocol has shown positive outcomes for patients wanting to manage their symptoms and improve function. The therapy has demonstrated a high rate of efficacy among individuals undergoing the full treatment course. This level of success shows its potential as a valuable option for pain control and managing neuropathic symptoms.

A primary benefit reported by patients is the restoration of mobility and function, particularly in the lower extremities where symptoms are often most severe. The protocol is designed to increase blood flow to the feet while at the same time triggering innate healing systems that are in a somewhat dormant setting in the body. But the improved circulation alone begins to happen at about Week 4 of treatment. This improved circulation is a critical factor, as it may assist in the regeneration of damaged nerves. This process is important for regaining sensation and improving balance.

Mercy Family Health in DuBois PA integrates the acoustic wave therapy into a wellness strategy to foster a sustainable healing environment. The full protocol is supplemented with personalized guidance on nutrition aimed at reducing systemic inflammation that can impede recovery as well as critical retraining of mechanical causes of the pain worsening. Patients also receive instruction on lifestyle strategies designed to support and sustain the body's natural healing processes.

Mercy Family Health is the provider of this protocol for nerve-related conditions. The company is focused on offering restorative health solutions that address the root causes of chronic issues, not just the symptoms. By combining advanced technology with supportive lifestyle strategies, Highroad Enterprises aims to help patients achieve lasting improvement and regain control over their health.

To learn more about Mercy Family Health or to schedule an initial consultation, please visit https://www.americastruehealth.com.

Contact Info:
Name: Stanley Lang
Email: Send Email
Organization: Highroad Enterprises
Address: 531 Delarme Road, DuBois, PA 15801, United States
Website: https://rxlyme.com/

Source: NewsNetwork

Release ID: 89169851

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.